Engaging neuron-intrinsic signaling for axon growth after spinal cord injury
脊髓损伤后轴突生长的神经元内在信号传导
基本信息
- 批准号:10213845
- 负责人:
- 金额:$ 61.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAnimal ModelAxonBackBehavioral AssayBrainCellsClinicCompetenceContralateralCorticospinal TractsDataDevelopmentDorsalEnterobacteria phage P1 Cre recombinaseFrequenciesGeneticGenetic RecombinationGoalsGrowthImageInjuryInterneuronsInterventionKnowledgeLabelLectinLeftLesionMAP2K1 geneMEKsMeasuresMicroscopyMissionMitogen-Activated Protein KinasesModelingMonitorMotor NeuronsMusNatural regenerationNeuronal InjuryNeuronsOptic NervePTEN geneParalysedPathway interactionsPeripheralPhotonsPilot ProjectsProcessProteinsPublic HealthRecovery of FunctionReporterResearchRoleSignal TransductionSiteSpinalSpinal CordSpinal cord injurySpinal cord injury patientsSynapsesTamoxifenTechniquesTestingTimeTracerTranslatingUnited States National Institutes of HealthWild Type MouseWorkaxon growthaxon regenerationaxonal sproutingbasecentral nervous system injuryclinical applicationcurative treatmentsfetalgain of functionin vivoinjuredinnovationinsightloss of functionmotor function recoverymouse modelneurotransmissionnovelpostsynapticpostsynaptic neuronspreclinical studyregenerativeregenerative growthrepairedrepetitive transcranial magnetic stimulationspinal nerve posterior rootsynaptic functionsynaptogenesistranscription factortreatment strategy
项目摘要
For victims of spinal cord injury (SCI) to recover motor function, large numbers of damaged
corticospinal tract (CST) axons would need to regenerate and re-connect with spinal inter- and motor
neurons. However, axons do not regenerate in the mature injured spinal cord. Decades of research
into this problem have yielded much insight into the mechanisms of axon growth and reasons why
they fail in the SCI context, but no strategies enabling long-range axon regeneration have emerged,
much less new treatments for SCI. To address this unmet need, my lab focuses on ways to re-
activate in mature injured CNS neurons the intracellular axon growth signaling mechanisms that are
active in developing neurons. The long-term goal of our research is to enable long-range axon
regeneration and the re-establishment of functional circuitry in the injured spinal cord. We have
recently observed that activation of RAF – MEK signaling in cortical motor neurons enables
substantial regenerative growth of injured CST axons in genetically modified mice. We observed
similar effects in wild type mice treated with repetitive transcranial stimulation (rTMS). The overall
objective of this application is to thoroughly explore the extent of axon regenerative growth and
synaptic re-connection that can be achieved by elevation of RAF – MEK signaling, or by rTMS. We
plan to pursue the following three Specific Aims: First, to determine how much CST axon
regeneration or sprouting can be stimulated in genetically modified B-RAF gain-of function mice
subjected to three different established models of SCI. Second, we have generated a novel
anterograde transsynaptic tracer by fusing the lectin WGA with the inducible Cre recombinase
CreERT2. Upon activation by tamoxifen, this tracer triggers the expression of a protein of choice in
postsynaptic neurons in a reporter mouse. We here plan to express the tracer in cortical motor
neurons, to induce expression of a genetically encoded fluorescent Ca2+ indicator in their
postsynaptic neurons. This will allow us to label new synapses formed by newly sprouting CST
axons, and also to demonstrate their functional activity as reflected in Ca2+ transients. Finally, we plan
to explore the power of rTMS to enable CST axon regeneration in wild type mice. Initial data indicate
that the level of MEK activity correlates with rTMS-dependent CST axon regeneration. Therefore, we
will use MEK1/2 conditional loss-of-function mice to test whether MEK activation is crucial for rTMS-
dependent regeneration. The proposed study is innovative, as it takes advantage of new technical
approaches (rTMS and the CreERT2WGA fusion tracer) to address the problem of long-range axon
regeneration in the spinal cord. This research is also significant because it tests new concepts and
strategies that may eventually contribute to axonal repair and functional recovery in SCI patients.
为了让脊髓损伤(SCI)的受害者恢复运动功能,大量受损的
皮质脊髓束(CST)轴突需要再生并与脊髓间轴和运动轴突重新连接
神经元。然而,轴突在成熟的受损脊髓中不会再生。数十年的研究
对这个问题的研究使我们对轴突生长的机制及其原因有了深入的了解
他们在 SCI 背景下失败了,但还没有出现能够实现远程轴突再生的策略,
更不用说针对 SCI 的新疗法了。为了解决这一未满足的需求,我的实验室重点研究如何重新
激活成熟受损中枢神经系统神经元的细胞内轴突生长信号机制
神经元发育活跃。我们研究的长期目标是实现远程轴突
受损脊髓的再生和功能回路的重建。我们有
最近观察到,皮质运动神经元中 RAF-MEK 信号的激活使得
转基因小鼠中受损的 CST 轴突显着再生生长。我们观察到
在接受重复经颅刺激(rTMS)治疗的野生型小鼠中也有类似的效果。整体
该应用的目的是彻底探索轴突再生生长的程度和
突触重新连接可以通过增强 RAF-MEK 信号传导或 rTMS 来实现。我们
计划追求以下三个具体目标: 第一,确定 CST 轴突的数量
转基因 B-RAF 功能获得性小鼠的再生或发芽可以得到刺激
受三种不同的已建立的 SCI 模型的影响。其次,我们生成了一本小说
通过将凝集素 WGA 与诱导型 Cre 重组酶融合来构建顺行突触示踪剂
CreERT2。被他莫昔芬激活后,该示踪剂会触发所选蛋白质的表达
报告小鼠的突触后神经元。我们这里计划在皮质运动中表达示踪剂
神经元,诱导其基因编码的荧光 Ca2+ 指示剂的表达
突触后神经元。这将使我们能够标记新萌芽的 CST 形成的新突触
轴突,并展示其功能活动(如 Ca2+ 瞬变所反映)。最后,我们计划
探索 rTMS 使野生型小鼠 CST 轴突再生的能力。初始数据表明
MEK 活性水平与 rTMS 依赖性 CST 轴突再生相关。因此,我们
将使用 MEK1/2 条件性功能丧失小鼠来测试 MEK 激活是否对 rTMS 至关重要-
依赖性再生。拟议的研究具有创新性,因为它利用了新技术
解决长程轴突问题的方法(rTMS 和 CreERT2WGA 融合示踪剂)
脊髓的再生。这项研究也很重要,因为它测试了新概念
最终可能有助于 SCI 患者轴突修复和功能恢复的策略。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Co-targeting B-RAF and PTEN Enables Sensory Axons to Regenerate Across and Beyond the Spinal Cord Injury.
- DOI:10.3389/fnmol.2022.891463
- 发表时间:2022
- 期刊:
- 影响因子:4.8
- 作者:Noristani, Harun N.;Kim, Hyukmin;Pang, Shuhuan;Zhong, Jian;Son, Young-Jin
- 通讯作者:Son, Young-Jin
FGF-induced Pea3 transcription factors program the genetic landscape for cell fate determination.
- DOI:10.1371/journal.pgen.1007660
- 发表时间:2018-09
- 期刊:
- 影响因子:4.5
- 作者:Garg A;Hannan A;Wang Q;Collins T;Teng S;Bansal M;Zhong J;Xu K;Zhang X
- 通讯作者:Zhang X
Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis.
- DOI:10.1371/journal.pgen.1007047
- 发表时间:2017-10
- 期刊:
- 影响因子:4.5
- 作者:Garg A;Bansal M;Gotoh N;Feng GS;Zhong J;Wang F;Kariminejad A;Brooks S;Zhang X
- 通讯作者:Zhang X
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian Zhong其他文献
Jian Zhong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian Zhong', 18)}}的其他基金
Engaging neuron-intrinsic signaling for axon growth after spinal cord injury
脊髓损伤后轴突生长的神经元内在信号传导
- 批准号:
9383972 - 财政年份:2017
- 资助金额:
$ 61.19万 - 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
- 批准号:
8520804 - 财政年份:2012
- 资助金额:
$ 61.19万 - 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
- 批准号:
8843867 - 财政年份:2012
- 资助金额:
$ 61.19万 - 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
- 批准号:
8658099 - 财政年份:2012
- 资助金额:
$ 61.19万 - 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
- 批准号:
8461561 - 财政年份:2012
- 资助金额:
$ 61.19万 - 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
- 批准号:
8275081 - 财政年份:2012
- 资助金额:
$ 61.19万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant














{{item.name}}会员




